Read e-book Immunostimulation

Free download. Book file PDF easily for everyone and every device. You can download and read online Immunostimulation file PDF Book only if you are registered here. And also you can download or read online all Book PDF file that related with Immunostimulation book. Happy reading Immunostimulation Bookeveryone. Download file Free Book PDF Immunostimulation at Complete PDF Library. This Book have some digital formats such us :paperbook, ebook, kindle, epub, fb2 and another formats. Here is The CompletePDF Book Library. It's free to register here to get Book file PDF Immunostimulation Pocket Guide.

Immunostimulation | Definition of Immunostimulation by Lexico

For permission for commercial use of this work, please see paragraphs 4. In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy.

We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

Journals Why Publish With Us? Advanced search.

Review ARTICLE

Home Journals Why publish with us? Abstract Fulltext Metrics Get Permission. S Review by Single-blind Peer reviewer comments 4. Accept In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'. Immunol Lett CTGAC-5 ,. A pharmaceutical formulation comprising the oligonucleotide and a physiologically acceptable carrier, such as the item I.

A method for generating an immune response in a vertebrate, said method comprising the immunostimulatory oligonucleotide having a structure from the group of administering to the vertebrate of nucleotides:. The method of claim 9, wherein the route of administration is selected from parenteral, oral, sublingual, transdermal, topical, intranasal, aerosol, intraocular, intratracheal, intrarectal, vaginal, gene gun, dermal patch, eye drop and mouthwash.

A method for treating cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, skin disorders, allergy, asthma or a disease caused by a pathogen of a vertebrate, the method comprising administering to the patient having a structure derived from the group of immunostimulatory oligonucleotides:. The method of claim 17, wherein the parenteral route of administration selected, ro, sublingual, transdermal, topical, intranasal, aerosol, intraocular, intratracheal, intrarectal, vaginal, gene gun, dermal patch, eye drops and rinse ro agent.

A method for preventing cancer in a vertebrate, an autoimmune disorder, airway inflammation, inflammatory disorders, skin disorders, allergy, a disease caused by a pathogen or asthma, the method comprising vertebrate administration having the structure derived from the group of immunostimulatory oligonucleotides:.

Bacteria in cancer therapy: beyond immunostimulation

The method of claim 25, wherein the parenteral route of administration selected, ro, sublingual, transdermal, topical, intranasal, aerosol, intraocular, intratracheal, intrarectal, vaginal, gene gun, dermal patch, eye drops and rinse ro agent. The oligonucleotide of claim I, further comprising an antibody, antisense oligonucleotide, protein, antigen, allergen, chemotherapeutic agent or adjuvant.

The pharmaceutical composition of claim 8, further comprising an antibody, antisense pharmaceutical composition, protein, antigen, allergen, chemotherapeutic agent or adjuvant.

The method according to [] Item 17, further comprising administering an antibody, antisense oligonucleotide, protein, antigen, allergen, chemotherapeutic agent or adjuvant. The method according to [] Item 25, further comprising administering an antibody, antisense oligonucleotide, protein, antigen, allergen, chemotherapeutic agent or adjuvant. Examples of immunostimulatory oligonucleotide sequences.

Services on Demand

Gennaro, MackPublishing Co. OOlmg to about mg per patient per day per kilogram of body weight per day. ImM IU mo I the scale synthesis of oligonucleotides. Mediatech to a final concentration of MO The invention relates to a therapeutic application of oligonucleotide serving as immunologic stimulant in immunotherapy application.

More particularly, the invention provides immunostimulation oligonucleotide; the immunostimulation oligonucleotide is used in a method used for generating immune response or used for patients who need immunostimulation; the immunostimulation oligonucleotide preferably comprises a new purine; the immunostimulation oligonucleotide also comprises at least two oligonucleotides; the at least two oligonucleotides are jointed between a 3'end and a nucleoside or are connected with a non-nucleotide joint on a functionalized nucleobase or saccharide; and at least one oligonucleotide is the immunostimulation oligonucleotide and is provided with an accessible 5'end.

How to Pronounce Immunostimulation

A pharmaceutical formulation comprising the oligonucleotide I and a physiologically acceptable carrier as claimed in claim. The oligonucleotide of claim I, further comprising a protein. The pharmaceutical formulation according to claim 2, further comprising antibodies, antisense oligonucleotides, antigen, allergen, chemotherapeutic agent or adjuvant.

The use as claimed in any one of claims 7, 8 or 9, wherein the drug administration route is selected from oral, sublingual, transdermal, intranasal, intraocular, intratracheal, rectal and vaginal. The use as claimed in any one of claims 9, wherein the medicament is administered non-gastrointestinal route. Use as claimed in any one of claims 9, wherein said route of administration is a topical medicament.

Immunostimulation through bacterial nucleic acids

Use as claimed in any one of claims 9, wherein the medicament is formulated as an aerosol, gene gun, dermal patch, eye drop or mouthwash. The use as claimed in any one of claims 7, 8 or 9, wherein said medicament with the antibody, antisense oligonucleotides, antigen, allergen, chemotherapeutic agent or in combination with adjuvants.

The use as claimed in any one of claims 9, wherein the protein associated with the drug. CN CNA en Immune stimulation speciality of compound containing modified immune irritation dinucleotide base on oligonucleotide. Comprising a modified immunostimulatory dinucleotide compounds based immune stimulating properties of the oligonucleotide. CNB en. Modified CpG sequence unit-containing oligodeoxynucleotide molecule and uses thereof.

CpG oligonucleotide with specific immunostimulation activity to human immune cell.


  • Background.
  • Immunostimulation and Immunosuppression: Nanotechnology on the Brink?
  • Quo Vadis Medical Healing: Past Concepts and New Approaches!
  • Donate to arXiv;